For example, SCLC cell lines are the most resistant to MEK inhibitors, whereas neuroblastoma cell lines exhibit intermediate sensitivity over a broader range (Supplementary Fig. S6A–S6C). This evidence concerns the gene MAP2K7 and small cell lung carcinoma.